IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.986
EU - Europa 7.308
AS - Asia 2.932
SA - Sud America 605
AF - Africa 72
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.914
GB - Regno Unito 2.187
RU - Federazione Russa 1.321
CN - Cina 1.223
IE - Irlanda 927
SG - Singapore 913
IT - Italia 738
UA - Ucraina 560
SE - Svezia 506
BR - Brasile 502
DE - Germania 352
FR - Francia 283
HK - Hong Kong 252
FI - Finlandia 193
KR - Corea 157
VN - Vietnam 151
NL - Olanda 70
IN - India 59
TR - Turchia 41
AR - Argentina 37
CA - Canada 33
ES - Italia 32
BE - Belgio 29
BD - Bangladesh 25
MX - Messico 25
ZA - Sudafrica 24
PL - Polonia 22
VE - Venezuela 17
AT - Austria 16
JP - Giappone 16
MA - Marocco 15
IQ - Iraq 14
PY - Paraguay 13
AU - Australia 11
CL - Cile 11
CZ - Repubblica Ceca 10
EC - Ecuador 9
CO - Colombia 8
EU - Europa 8
UZ - Uzbekistan 8
BG - Bulgaria 7
IR - Iran 7
TN - Tunisia 7
CH - Svizzera 6
CI - Costa d'Avorio 6
JO - Giordania 6
KE - Kenya 6
LT - Lituania 6
PK - Pakistan 6
RO - Romania 6
GR - Grecia 5
IL - Israele 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
DZ - Algeria 4
EE - Estonia 4
EG - Egitto 4
HU - Ungheria 4
ID - Indonesia 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
OM - Oman 4
CY - Cipro 3
GE - Georgia 3
KZ - Kazakistan 3
PA - Panama 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
ET - Etiopia 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
Totale 19.923
Salva come PNG Salva come JPEG
Città #
Southend 2.032
Fairfield 1.252
Dublin 909
Dallas 852
Ashburn 651
Woodbridge 591
Chandler 581
Wilmington 474
Seattle 465
Jacksonville 451
Singapore 443
Houston 442
Santa Clara 430
Cambridge 407
Beijing 340
Moscow 328
Ann Arbor 290
Siena 279
Hong Kong 246
Seoul 154
Nanjing 153
Princeton 149
Hefei 131
Los Angeles 115
Helsinki 82
Boardman 81
Munich 66
San Diego 64
The Dalles 64
Dong Ket 56
Nanchang 55
New York 55
Buffalo 47
Amsterdam 44
São Paulo 42
San Mateo 41
Saint Petersburg 40
Düsseldorf 36
Milan 36
Council Bluffs 34
London 34
Ho Chi Minh City 32
Florence 31
Shanghai 31
Tianjin 31
Turku 30
Shenyang 29
Brussels 27
Kunming 27
Jiaxing 26
Lancaster 26
Chicago 25
Changsha 24
Hebei 24
Columbus 23
Guangzhou 22
Washington 22
Izmir 21
Jinan 20
Prato 20
Dearborn 19
Hanoi 18
Norwalk 18
Redondo Beach 18
Redwood City 18
Zhengzhou 18
Brooklyn 15
Denver 15
Málaga 15
Ningbo 15
Rome 14
San Francisco 14
Tokyo 14
Warsaw 14
Belo Horizonte 13
Johannesburg 13
Montreal 13
Phoenix 13
Renton 13
Brasília 12
Venezia 12
Chennai 11
Rio de Janeiro 11
East Falmouth 10
Stockholm 10
Vienna 10
Ankara 9
Atlanta 9
Hangzhou 9
Menlo Park 9
Nuremberg 9
Toronto 9
Bengaluru 8
Boston 8
Orem 8
Campinas 7
Caxias do Sul 7
Curitiba 7
Frankfurt am Main 7
Guarulhos 7
Totale 14.012
Salva come PNG Salva come JPEG
Nome #
null 398
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 348
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 347
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 300
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 297
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 289
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 286
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 278
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 275
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 264
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 263
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 260
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 258
Approach to and treatment of differentiated thyroid carcinoma 257
Acute exogenous TSH administration stimulates leptin secretion in vivo 254
Reference range of serum calcitonin in pediatric population 248
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 247
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 246
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 232
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 227
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 226
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 223
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 221
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 219
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 218
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 216
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 215
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 214
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 213
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 212
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 212
Changing natural history of differentiated thyroid cancer 209
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 207
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 207
Management of thyroid nodules: a clinicopathological, evidence-based approach 206
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 205
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 203
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 202
Management of papillary thyroid microcarcinoma: primum non nocere! 201
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 201
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 197
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 193
Ernest L. Mazzaferri, MD, MACP (1936-2013) 189
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 187
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 187
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 186
Medullary thyroid carcinoma 186
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 186
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 183
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 180
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 180
Screening of thyroid nodules by serum calcitonin measurements: why not? 177
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 175
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 175
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 173
Management of differentiated thyroid cancer of the follicular epithelium 172
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 171
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 170
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 170
Post-thyroidectomy chronic asthenia: self-deception or disease? 169
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 168
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 168
Multinodular goiter of unusual shape and location 167
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 167
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 167
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 167
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 164
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 163
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 162
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 160
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 160
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 159
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 159
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 157
Telomeres and thyroid cancer 155
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 154
Management of advanced medullary thyroid cancer 154
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 152
The low utility of pretherapy scans in thyroid cancer patients 151
Targeted therapy in refractory thyroid cancer: current achievements and limitations 150
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 150
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 149
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 148
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 147
Rare diseases in clinical endocrinology: a taxonomic classification system 147
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 147
New insight in the follow-up strategies of differentiated thyroid cancer 145
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 143
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 142
Radioiodine therapy in the different stages of differentiated thyroid cancer 140
Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand 140
Thyroid microcarcinoma 140
Medullary thyroid cancer: management guidelines of the American Thyroid Association 138
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 136
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome 135
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 132
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 127
null 126
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 124
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 120
Totale 19.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.546 0 0 0 0 0 289 133 372 177 232 161 182
2021/20221.276 132 183 70 97 68 52 62 41 82 142 141 206
2022/20231.937 114 172 258 268 193 380 38 169 212 32 72 29
2023/20241.250 67 30 106 39 52 351 458 19 6 18 16 88
2024/20252.846 56 138 243 139 388 197 96 143 238 97 396 715
2025/20263.905 528 912 627 728 1.053 57 0 0 0 0 0 0
Totale 20.120